VCA-894A

N/A

Report date: 2025/11/04 20:00:06
NME

Base Information

Drug NameVCA-894A
Drug Alias NameVCA-894A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionDNA-binding protein SMUBP-2 inhibitorsGene expression modulators
TargetsDNA-binding protein SMUBP-2
Therapy Area/IndicationsNeuromuscular DiseasesCharcot-Marie-Tooth Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesVanda Pharmaceuticals IncOlipass Co
China Registration ClassN/A

Develop Information

Active CompaniesVanda Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsNeuromuscular DiseasesCharcot-Marie-Tooth Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A